Evidence map›Paper›PMID 41356646›Full record

ArticleClinical case reports2025

First Case of Primary Breast Melanoma in Central America: Case Report and Literature Review.

Ana García-Urbina, Denis Espinoza-Vásquez, Johanna Obregón-Silva, Arlin Montoya Rodríguez

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana García-UrbinaDepartment of General Surgery Manolo Morales Peralta Hospital Managua Nicaragua.ORCID https://orcid.org/0009-0007-2071-5264
Denis Espinoza-VásquezDepartment of Oncology Manolo Morales Peralta Hospital Managua Nicaragua.ORCID https://orcid.org/0009-0008-3635-3744
Johanna Obregón-SilvaDepartment of General Surgery Manolo Morales Peralta Hospital Managua Nicaragua.ORCID https://orcid.org/0009-0004-3081-7764
Arlin Montoya RodríguezDepartment of Obstetric Critical Care and Internal Medicine Bertha Calderón Roque Hospital Managua Nicaragua.ORCID https://orcid.org/0000-0002-9353-4313

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary breast melanoma is an exceedingly rare neoplasm, accounting for < 0.5% of all malignant breast tumors. Its scarcity and highly variable clinical presentation often delay diagnosis and complicate management. We report the case of a 55-year-old woman with a primary non-cutaneous melanoma of the right breast initially misdiagnosed as high-grade ductal carcinoma. As a result of discordant biopsy results, the lesion progressed developing ulceration, tissue destruction, and axillary metastases. Definitive diagnosis was established via repeated incisional biopsies and immunohistochemistry. Management comprised neoadjuvant dacarbazine (discontinued owing to toxicity and disease progression), modified radical mastectomy, delayed split-thickness skin graft, targeted antibiotic therapy for a carbapenemase-producing infection, adjuvant carboplatin-paclitaxel, and locoregional radiotherapy. Twelve months later, right-side inguinal nodal metastases were resected and irradiated. At 18-month follow-up, the patient remains disease-free. This case underscores the diagnostic and therapeutic challenges of primary breast melanoma and highlights the importance of early multidisciplinary care.

Indexed as

breast cancerCARE guidelinescase reportcutaneous melanomaprimary breast melanoma

Identifiers

PMID41356646
PMCPMC12674960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.